Monoclonal mast cell disorders encompass mast cell-related conditions in which investigations provide evidence of clonality. In most cases, this evidence is based on the detection of an activating ...

Applicable to mast cell-driven inflammatory and oncologic conditions. Positioned for orphan indications and expedited regulatory pathways. HT-KIT is one of several novel platforms under development at ...

Protection through 2039, ensuring long-term commercial exclusivity. NEW YORK, June 12, 2025 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharmaceutical company ...

Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharmaceutical company developing innovative therapies, today announced that they have obtained Japan Country Patent No. 7677628 for the ...

Hoth Therapeutics Secures Japanese Patent for Breakthrough HT-KIT Platform Targeting Mast Cell Diseases. By Hoth Therapeutics, Inc. Jun 12, 2025 Jun 12, 2025 Updated Jun 12, 2025; ...

A new study from The University of Texas at Arlington details a novel strategy for how the body clears out dead cells during stress, revealing unexpected roles for well-known stress-response genes ...

A Michigan woman living with sickle cell disease says her life may now be at risk after the CDC disbanded the team responsible for researching safe birth control for people with chronic conditions ...

Each activated T cell can generate up to 400,000 apurinic/apyrimidinic (A/P) sites in a single day. These are spots where the DNA base is missing—a type of lesion that threatens the stability of ...

Leaders from the world of cell and gene therapy, including molecular geneticists, immunotherapists, physicians, nonprofit directors, and patient advocates, shared their personal stories and policy ...

15-year-old Jayden Wilsey is the first patient at Boston Children's Hospital to receive human gene therapy for sickle cell disease. The treatment, Casgevy, modifies the patient's stem cells to ...

Landmark trials using stem cells to treat Parkinson’s disease in the USA and Japan mark a turning point for cell therapy in neurodegeneration. Similar approaches to Alzheimer’s disease and ...